SCHEMBL7367307

SCHEMBL7367307

N#Cc1cccnc1Oc1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.50
CNR1 P21554 2/20 0.49
CNR2 P34972 2/20 0.49
CYP19A1 P11511 2/20 0.48
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
PGGT1B P53609 1/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
PIN1 Q13526 1/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 1/20 0.43
PPP1CA P62136 1/20 0.43
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9040019 0.84 MEN1 (0.49) CYP19A1FNTAFNTBPGGT1BPIN1
SCHEMBL3287871 0.83 ALDH1A1 (0.44) CYP19A1PIN1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL10955865 0.82 KDM4E (0.53) ARCYP19A1FNTAFNTBPGGT1B
SCHEMBL9038839 0.82 RAB9A (0.59) ARCYP19A1FNTAFNTBPGGT1B
SCHEMBL3293477 0.81 ALDH1A1 (0.55) PIN1ALDH1A1SMN1; SMN2KMT2AMAPT
SCHEMBL13333183 0.80 ALDH1A1 (0.41) CYP19A1FNTAFNTBPGGT1BPIN1
SCHEMBL3167158 0.79 F10 (0.42) CYP19A1ALDH1A1SMN1; SMN2KMT2AMEN1
Methyl Alcohol SCHEMBL11374946 0.77 MEN1 (0.55) PIN1ALDH1A1SMN1; SMN2KMT2AMAPT
SCHEMBL7364733 0.77 EGFR (0.47) CYP19A1PDE4APDE4BPDE4CPDE4D
SCHEMBL3287938 0.77 ALDH1A1 (0.62) CYP19A1PIN1ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed